Risk assessment on change of testing requirements for partner donation of reproductive cells
In May 2011, the European Commission asked ECDC to estimate the change in total exposure risk to hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) during reproductive cell handling and storage for secondary parties, if the current scheme of testing at each cell donation would change to testing partner donors of reproductive cells once or twice a year.
Based on initial findings, ECDC developed a model for the estimation of the residual risk of infection using data supplied by the European Society of Human Reproduction and Embryology.
Based on initial findings, ECDC developed a model for the estimation of the residual risk of infection using data supplied by the European Society of Human Reproduction and Embryology. Residual risks under the different testing procedures were compared in order to estimate the possible change in risk.
The ECDC risk assessment concludes that the estimated residual risks of an HIV, HBV or HCV infection being transmitted by undetected infection of reproductive cells donated for medically assisted reproduction was found to be relatively small, but not insignificant. If donors were tested at entry and then only every 24 months, an additional 0.5 (HIV), two (hepatitis B) and nine (hepatitis C) cases would be missed for each one million person years. If donors were tested every 12 months, the increases would be even smaller, thereby not constituting a significant increase in residual risk.
Risk assessment: The risk of variant Creutzfeldt-Jakob disease transmission via blood and plasma-derived medicinal products manufactured from donations obtained in the United Kingdom
3 Aug 2021 - ECDC assessed the risk to the EU/EEA of the presence and the possible transmission of prions, which have been linked to to Creutzfeldt-Jakob disease, by blood and plasma-derived medicinal products (PDMPs) manufactured from donations obtained in the UK.
Rapid Risk Assessment: Extreme rainfall and catastrophic floods in western Europe
29 Jul 2021 - Extreme rainfall on 14 and 15 July 2021 and subsequent flooding in Western Europe has taken a high number of human lives and caused substantial damage to community infrastructure and the environment. This rapid risk assessment focuses on the most common infectious diseases and health risks associated with flood-affected areas, taking into account evidence from previous similar events in Europe.
Rapid Risk Assessment: COVID-19 outbreaks in long-term care facilities in the EU/EEA in the context of current vaccination coverage
26 Jul 2021 - Coronavirus disease (COVID-19) outbreaks in long-term care facilities (LTCFs) in European Union and European Economic Area (EU/EEA) countries have caused significant morbidity and mortality since the beginning of the COVID-19 pandemic.